source
- Former Legend Biotech CEO Ying Huang appointed head of K2 Therapeutics as startup secures $50M seed fundingYing Huang, who led Legend Biotech for seven years and helped develop a top‑selling cell therapy for multiple myeloma, has been named chief executive of K2 Therapeutics. The young company, founded…
- Amgen to open new R&D Science and Innovation Center in Hyderabad's Genome Valley by 2027Amgen announced plans to establish a Science and Innovation Center in Hyderabad's Genome Valley, a biotech hub in India. The facility is slated to open in 2027 and will become part of Amgen's globa…